Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.

Acharya D, Paul AM, Anderson JF, Huang F, Bai F.

PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004139. doi: 10.1371/journal.pntd.0004139. eCollection 2015.

2.

Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.

Ashbrook AW, Burrack KS, Silva LA, Montgomery SA, Heise MT, Morrison TE, Dermody TS.

J Virol. 2014 Nov;88(21):12180-92. doi: 10.1128/JVI.01672-14. Epub 2014 Aug 20.

3.

A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.

Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, Dermody TS.

J Virol. 2014 Mar;88(5):2385-97. doi: 10.1128/JVI.03116-13. Epub 2013 Dec 26.

4.

Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.

Jones JE, Long KM, Whitmore AC, Sanders W, Thurlow LR, Brown JA, Morrison CR, Vincent H, Peck KM, Browning C, Moorman N, Lim JK, Heise MT.

MBio. 2017 Nov 14;8(6). pii: e01456-17. doi: 10.1128/mBio.01456-17.

5.

Chikungunya virus induces a more moderate cytopathic effect in mosquito cells than in mammalian cells.

Li YG, Siripanyaphinyo U, Tumkosit U, Noranate N, A-nuegoonpipat A, Tao R, Kurosu T, Ikuta K, Takeda N, Anantapreecha S.

Intervirology. 2013;56(1):6-12. doi: 10.1159/000339985. Epub 2012 Aug 16.

6.

Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.

Pal P, Fox JM, Hawman DW, Huang YJ, Messaoudi I, Kreklywich C, Denton M, Legasse AW, Smith PP, Johnson S, Axthelm MK, Vanlandingham DL, Streblow DN, Higgs S, Morrison TE, Diamond MS.

J Virol. 2014 Aug;88(15):8213-26. doi: 10.1128/JVI.01032-14. Epub 2014 May 14.

7.

Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.

Taylor A, Liu X, Zaid A, Goh LY, Hobson-Peters J, Hall RA, Merits A, Mahalingam S.

MBio. 2017 Feb 21;8(1). pii: e01970-16. doi: 10.1128/mBio.01970-16.

8.

A Chikungunya Virus trans-Replicase System Reveals the Importance of Delayed Nonstructural Polyprotein Processing for Efficient Replication Complex Formation in Mosquito Cells.

Bartholomeeusen K, Utt A, Coppens S, Rausalu K, Vereecken K, Ariën KK, Merits A.

J Virol. 2018 Jun 29;92(14). pii: e00152-18. doi: 10.1128/JVI.00152-18. Print 2018 Jul 15.

9.

Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.

Rothan HA, Bahrani H, Abdulrahman AY, Mohamed Z, Teoh TC, Othman S, Rashid NN, Rahman NA, Yusof R.

Antiviral Res. 2016 Mar;127:50-6. doi: 10.1016/j.antiviral.2016.01.006. Epub 2016 Jan 18.

PMID:
26794398
10.

Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.

Ashbrook AW, Lentscher AJ, Zamora PF, Silva LA, May NA, Bauer JA, Morrison TE, Dermody TS.

MBio. 2016 May 24;7(3). pii: e00693-16. doi: 10.1128/mBio.00693-16.

11.

ADP-ribosylhydrolase activity of Chikungunya virus macrodomain is critical for virus replication and virulence.

McPherson RL, Abraham R, Sreekumar E, Ong SE, Cheng SJ, Baxter VK, Kistemaker HA, Filippov DV, Griffin DE, Leung AK.

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1666-1671. doi: 10.1073/pnas.1621485114. Epub 2017 Jan 31.

12.

Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by Aedes Mosquitoes.

Delang L, Yen PS, Vallet T, Vazeille M, Vignuzzi M, Failloux AB.

mSphere. 2018 Aug 22;3(4). pii: e00230-18. doi: 10.1128/mSphere.00230-18.

13.

Mosquito saliva induced cutaneous events augment Chikungunya virus replication and disease progression.

Agarwal A, Joshi G, Nagar DP, Sharma AK, Sukumaran D, Pant SC, Parida MM, Dash PK.

Infect Genet Evol. 2016 Jun;40:126-135. doi: 10.1016/j.meegid.2016.02.033. Epub 2016 Feb 27.

PMID:
26925703
14.

Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology.

Teo TH, Her Z, Tan JJ, Lum FM, Lee WW, Chan YH, Ong RY, Kam YW, Leparc-Goffart I, Gallian P, Rénia L, de Lamballerie X, Ng LF.

J Virol. 2015 Aug;89(15):7955-69. doi: 10.1128/JVI.00909-15. Epub 2015 May 20.

15.

Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication.

Scholte FE, Tas A, Albulescu IC, Žusinaite E, Merits A, Snijder EJ, van Hemert MJ.

J Virol. 2015 Apr;89(8):4457-69. doi: 10.1128/JVI.03612-14. Epub 2015 Feb 4.

16.

Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes.

Göertz GP, Lingemann M, Geertsema C, Abma-Henkens MHC, Vogels CBF, Koenraadt CJM, van Oers MM, Pijlman GP.

PLoS Negl Trop Dis. 2018 Nov 9;12(11):e0006958. doi: 10.1371/journal.pntd.0006958. eCollection 2018 Nov.

17.

Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.

Langsjoen RM, Auguste AJ, Rossi SL, Roundy CM, Penate HN, Kastis M, Schnizlein MK, Le KC, Haller SL, Chen R, Watowich SJ, Weaver SC.

Antiviral Res. 2017 Jul;143:246-251. doi: 10.1016/j.antiviral.2017.04.014. Epub 2017 Apr 28.

PMID:
28461071
18.

Identification of Functional Determinants in the Chikungunya Virus E2 Protein.

Weber C, Berberich E, von Rhein C, Henß L, Hildt E, Schnierle BS.

PLoS Negl Trop Dis. 2017 Jan 23;11(1):e0005318. doi: 10.1371/journal.pntd.0005318. eCollection 2017 Jan.

19.

The time course analysis of morphological changes induced by Chikungunya virus replication in mammalian and mosquito cells.

Ghosh A, Alladi PA, Narayanappa G, Vasanthapuram R, Desai A.

Acta Virol. 2018;62(4):360-373. doi: 10.4149/av_2018_403.

PMID:
30472865
20.

Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion.

van Duijl-Richter MK, Hoornweg TE, Rodenhuis-Zybert IA, Smit JM.

Viruses. 2015 Jul 7;7(7):3647-74. doi: 10.3390/v7072792. Review.

Supplemental Content

Support Center